Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/1996
10/10/1996WO1996031601A1 Polynucleotide immunogenic agents
10/10/1996WO1996031599A1 Ndf peptides
10/10/1996WO1996031598A1 Tie-2 ligands, methods of making and uses thereof
10/10/1996WO1996031597A1 Ascorbate peroxidase and assays using same
10/10/1996WO1996031537A1 Agents for binding to advanced glycosylation endproducts, and methods of their use
10/10/1996WO1996031536A1 Synthetic calcitonin mimetics
10/10/1996WO1996031535A1 Process for purifying filamentary haemagglutinin and pertussis toxin
10/10/1996WO1996031534A1 ISOLATED NUCLEIC ACID MOLECULES ENCODING p57KIP2 AND USES OF SAME
10/10/1996WO1996031531A2 Fluorescent peptides
10/10/1996WO1996031529A1 Peptides and remedy for autoimmune diseases comprising the same
10/10/1996WO1996031528A1 Beta sheet forming peptides and gels made thereof
10/10/1996WO1996031526A1 Anti-obesity agents
10/10/1996WO1996031521A1 Inhibiting degradation of a degron-bearing protein
10/10/1996WO1996031496A1 Methadone derivatives and protein and polypeptide methadone derivative conjugates and labels
10/10/1996WO1996031243A1 Ternary radiopharmaceutical complexes
10/10/1996WO1996031242A1 RECOMBINANT β-CELL AND USES THEREOF
10/10/1996WO1996031241A1 Transplantation of genetically modified cells having low levels of class i mhc proteins on the cell surface
10/10/1996WO1996031236A1 Chlamydia vaccines
10/10/1996WO1996031230A1 Medicinal composition for curing thrombocytopenia
10/10/1996WO1996031229A1 Inhibiting rejection of a graft
10/10/1996WO1996031220A1 Cyclodextrin compounds and methods of making and use thereof
10/10/1996WO1996031113A1 Plants with altered mitochondrial function
10/10/1996WO1996026958A3 Eph receptor ligand elf-2
10/10/1996WO1996021465A3 Immunogenic conjugate molecules
10/10/1996WO1996021416A3 Methods and compositions for treatment of solid tumors in vivo
10/10/1996WO1996020215A3 Use of mhc-ii binding and/or mhc-ii mimicking molecules for the prevention and/or treatment of inflammatory diseases
10/10/1996WO1996016182A3 Microspore-specific regulatory element
10/10/1996WO1996016175A3 Lgmd gene coding for a calcium dependent protease
10/10/1996WO1996012737A3 Compositions and treatment for multiple sclerosis
10/10/1996WO1996012009A3 Methods for engineering antigen-presenting cells
10/10/1996WO1996001430A3 Screening for nuc inhibitors
10/10/1996WO1995000554A3 Totipotent hematopoietic stem cell receptors and their ligands
10/10/1996DE19518488C1 Autoantigen, geeignet zur Feststellung einer Thromboseneigung Autoantigen, suitable for detection of thrombosis
10/10/1996DE19512937A1 Neuer Inhibitor des Erythrina caffra Typs und dessen Verwendung zur Reinigung von Serinproteasen New inhibitor of Erythrina caffra type and its use for the purification of serine proteases
10/10/1996DE19512463A1 Gene and cDNA encoding human cytokine HCC-1
10/10/1996CA2217697A1 Cancer diagnosis and therapy based on mutations in tgf-beta receptors
10/10/1996CA2217652A1 Recombinant .beta.-cell and uses thereof
10/10/1996CA2217641A1 Polypeptides having a functional domain of interest and methods of identifying and using same
10/10/1996CA2217572A1 Agents for binding to advanced glycosylation endproducts, and methods of their use
10/10/1996CA2217491A1 Polynucleotide immunogenic agents
10/10/1996CA2217450A1 Use of an "immunodeficiency-virus suppressing lymphokine (isl)" to inhibit the replication of viruses, in particular of retroviruses
10/10/1996CA2217346A1 Method of production of antigen-specific glycosylation inhibiting factor
10/10/1996CA2217305A1 Cyclodextrin compounds and methods of making and use thereof
10/10/1996CA2217297A1 Transplantation of genetically modified cells having low levels of class i mhc proteins on the cell surface
10/10/1996CA2217154A1 Methadone derivatives and protein and polypeptide methadone derivative conjugates and labels
10/10/1996CA2216406A1 Plant pathogen resistance genes and uses thereof
10/10/1996CA2216092A1 Expression library immunization
10/10/1996CA2213620A1 Antibodies for the detection of hla-g
10/09/1996EP0736605A1 Process for producing proteins
10/09/1996EP0736601A2 Non-A, non-B, non-C, non-D, non-E hepatitis reagents and methods for their use
10/09/1996EP0736600A2 Use of an "immunodeficiency-virus suppressing lymphokine (ISL)" to inhibit the replication of viruses, in particular of retroviruses
10/09/1996EP0736599A2 Rat obese gene, its gene product and its production
10/09/1996EP0736543A2 Method for the production of monoclonal antibodies to proliferation-associated antigens of the cell nucleus
10/09/1996EP0736542A1 Peptides that induce antibodies which inhibit HIV-type retroviruses and antibodies specific for these peptides
10/09/1996EP0736303A2 Interferon solution
10/09/1996EP0736179A1 Differentiation of htlv-i and htlv-ii using synthetic peptides
10/09/1996EP0736106A1 Methods of screening for beta-amyloid peptide production inhibitors
10/09/1996EP0736102A1 Method for preparing peptide products, and resulting products
10/09/1996EP0736100A1 Recombinant protein production in bovine adenovirus expression vector system
10/09/1996EP0736099A1 Expression of self-processing polyproteins in transgenic plants
10/09/1996EP0736098A1 Mycobacteria virulence factors and a method for their identification
10/09/1996EP0736097A1 Plant pathogen resistance genes and uses thereof
10/09/1996EP0736096A1 Antimicrobial proteins
10/09/1996EP0736095A1 Human circulating cytokine cc-1
10/09/1996EP0736094A1 Polycystic kidney disease 1 gene and uses thereof
10/09/1996EP0736042A1 Markers of organ rejection
10/09/1996EP0736040A1 Use of igf-bp for refolding of igf
10/09/1996EP0736039A1 Compounds with growth hormone releasing properties
10/09/1996EP0736038A1 Compounds with growth hormone releasing properties
10/09/1996EP0736034A1 Dna encoding the wnt-x growth factor
10/09/1996EP0736027A1 Guanine synthons for peptide nucleic acid synthesis and method for production
10/09/1996EP0735893A1 Alteration of immune response using pan dr-binding peptides
10/09/1996EP0735891A1 A 46 Kd HUMAN MILK FAT GLOBULE ANTIGEN
10/09/1996EP0735889A1 A novel tumor suppressor gene
10/09/1996EP0735818A1 MACROPHAGE INFLAMMATORY PROTEINS-3, -4 AND -1 Sg(g)
10/09/1996EP0724648A4 Methods for screening antiestrogen compounds
10/09/1996EP0528928B1 Interleukin-4 binding protein-gamma
10/09/1996EP0528820B1 Methods and compositions for the identification, characterization and inhibition of farnesyl protein transferase
10/09/1996CN1133064A GRB3-3 gene, variants and uses thereof
10/09/1996CN1133063A DNA Molecule encoding for cellular uptake of mycobacterium tuberculosis
10/09/1996CN1133050A Composition and methods using nitroxides to avoid oxygen toxicity
10/09/1996CN1133049A Melanona-inhibiting protein
10/09/1996CN1133048A Oligopeptides derived from C-reactive protein fragments
10/09/1996CN1133047A Therapeutic peptide derivatives
10/08/1996US5563254 Polynucleotides encoding genetically engineered mutant hemoglobins
10/08/1996US5563246 Sodium ion binding proteins
10/08/1996US5563245 Anti-obesity proteins
10/08/1996US5563244 Anti-obesity proteins
10/08/1996US5563243 Anti-obesity proteins
10/08/1996US5563124 Osteogenic product and process
10/08/1996US5563123 Chimeric proteins
10/08/1996US5563121 Phosphinate methylene ammonium linkage
10/08/1996US5563120 Cytokine preparation for immunotherapy
10/08/1996US5563074 Immunological detection methods
10/08/1996US5563048 Human stromal derived factor 1α and 1β, and DNAs encoding the same
10/08/1996US5563047 Treating with transglutaminase, inactivating the transglutaminase at a desired degree of polymerization
10/08/1996US5563046 Nucleic acid encoding fusion protein or polypeptide comprising interleukin-like polypeptide, linker, polypeptide of interest
10/08/1996US5563045 Porcine factor viii nucleotide sequences
10/08/1996US5563044 Process for the enzymatic preparation of GRF(1-44)NH2
10/08/1996US5563041 Method for determining platelet aggregation
1 ... 2520 2521 2522 2523 2524 2525 2526 2527 2528 2529 2530 2531 2532 2533 2534 2535 2536 2537 2538 2539 2540 ... 2916